TI). Combined
with a new systematic review and meta-analysis,2 these
documents represent 5 years of work by an international
team of vascular specialists, each with recognized expertise in peripheral arterial disease (PAD). The guidelines
considered evidence on all therapies currently available
throughout the world to treat this important global
problem and the end result is a monumental work of
exceptional quality.
CLTI, a new term used in the guidelines instead of critical limb ischemia, is deÔ¨Å